investment Archives - Page 2 of 2

FACIT generates $1.5 billion in follow-on investment

Posted on March 29, 2023 (September 15, 2024) by nicole

March 29, 2023 – FACIT announced $1.5 billion in follow-on investment attracted to its portfolio of cancer biotechnology start-ups in Ontario, a significant milestone for life science commercialization in Canada.

CTRL Therapeutics, a FACIT-backed start-up, raises US$10M to develop autologous cell therapy for patients living with cancer

Posted on March 23, 2023 (October 20, 2025) by nicole

March 23, 2023 – CTRL Therapeutics (“CTRL”) closed a seed financing round to develop a tumor-infiltrating lymphocyte (TIL) therapy for solid tumours. CTRL is advancing novel, non-invasive and less costly therapies for patients living with cancer.

FACIT’s Prospects Fund invests in two emerging Ontario diagnostics for colorectal and prostate cancers

Posted on September 16, 2021 (September 13, 2024) by jeremy

September 16, 2021 – September 16, 2021 – Both innovations were previous finalists in FACIT’s 2021 Falcons’ Fortunes pitch competition.

FACIT leads seed round in Nanology Labs

Posted on May 18, 2021 (July 4, 2024) by jeremy

May 18, 2021 – May 18, 2021 – FACIT deploys Ontario First capital, enables rising local start-up to reach critical value inflection point. FACIT has previously supported Nanology, spun out of the University of Toronto, through both its early-stage Prospects Oncology Fund and seed-stage Compass Rose Oncology Fund.

FACIT crowns 2021 winner of Falcons’ Fortunes pitch competition; announces follow-on investment in 2020 winner, Bridge7 Oncology

Posted on February 4, 2021 (July 4, 2024) by jeremy

February 4, 2021 – February 4, 2021 – FACIT’s Prospects Oncology Fund and its annual pitch competition help to advance Ontario oncology innovations.

FACIT fuels promising made-in-Ontario breast cancer therapeutic and medtech innovations through Prospects Oncology Fund

Posted on December 10, 2020 (July 4, 2024) by jeremy

December 10, 2020 – December 10, 2020 – The newest recipients of Ontario First seed capital include Dr. Rebecca Laposa of the University of Toronto, as well as London-based start-up Multi-Magnetics Inc.

FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)

Posted on June 9, 2020 (July 4, 2024) by jeremy

June 9, 2020 – June 9, 2020 – FACIT’s award was specifically related to the 2019 historic US$1B partnership between its portfolio companies, Propellon Therapeutics and Triphase Accelerator, and US pharma giant Celgene (acquired by Bristol-Myers Squibb Company).

FACIT announces follow-on investments in Xpan Inc. and Nanology Labs through Compass Rose Fund

Posted on January 28, 2020 (July 4, 2024) by jeremy

January 28, 2020 – January 28, 2020 – Spun out of the University of Toronto, both start-ups have previously received funding through FACIT’s proof-of-concept Prospects Fund.

FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund

Posted on July 10, 2017 (October 11, 2024) by jeremy

July 10, 2017 – Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from FACIT’s new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies.